Author:
Mohamed O,Freundlich R E,Dakik H K,Grober E D,Najari B,Lipshultz L I,Khera M
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Morales A, Tenover JL . Androgen deficiency in the aging male: when, who, and how to investigate and treat. Urol Clin North Am 2002; 29: 975–982.
2. Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 2008; 93: 2737–2745.
3. Kiratli BJ, Srinivas S, Perkash I, Terris MK . Progressive decrease in bone density over 10 years of androgen deprivation therapy in patients with prostate cancer. Urology 2001; 57: 127–132.
4. Stoch SA, Parker RA, Chen L, Bubley G, Ko YJ, Vincelette A et al. Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 2001; 86: 2787–2791.
5. Stepan JJ, Lachman M, Zverina J, Zverina J, Pacovsky V, Baylink DJ . Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 1989; 69: 523–527.
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献